From: Anxiety management in Australian general practice: an analysis of encounters from 2006 – 2016
Benzodiazepines | SSRIs or SNRIs | CAE | Psychologist Referral | |||||
---|---|---|---|---|---|---|---|---|
Variable | Proportion (95%CI) | Adjusted OR (95%CI) | Proportion (95% CI) | Adjusted OR (95%CI) | Proportion (95% CI) | Adjusted OR (95%CI) | Proportion (95% CI) | Adjusted OR (95%CI) |
Practice location | p = .641 | p = .003 | p = .035 | p = .004 | ||||
Major city | 29.2% (28.2–30.2) | 1.04 (0.89–1.23) | 45.2% (44.1–46.2) | 1.26 (1.07–1.48) | 12.8% (12.3–13.4) | 1.19 (0.97–1.47) | 20.6% (19.8–21.3) | 0.90 (0.77–1.05) |
Inner regional | 32.0% (30.1–34.0) | 0.99 (0.83–1.18) | 39.8% (37.9–41.7) | 1.09 (0.92–1.30) | 10.7% (9.8–11.7) | 1.02 (0.81–1.28) | 23.2% (21.8–24.6) | 1.08 (0.91–1.28) |
Outer regional/remote | 32.7% (29.8–35.6) | Ref group | 39.2% (36.2–42.3) | Ref group | 9.9% (8.5–11.4) | Ref group | 21.3% (19.3–23.4) | Ref group |
Practice size | p = .315 | p = .658 | p = .017 | p = .001 | ||||
Solo GP | 42.0% (38.1–46.0) | Ref group | 39.3% (35.8–42.9) | Ref group | 6.5% (5.4–7.6) | Ref group | 14.4% (12.7–16.1) | Ref group |
2–4 GPs | 31.2% (29.5–32.9) | 0.87 (0.71–1.07) | 44.4% (42.7–46.1) | 1.07 (0.88–1.29) | 11.2% (10.4–12.0) | 1.33 (1.05–1.70) | 20.8% (19.7–21.9) | 1.46 (1.21–1.76) |
5–9 GPs | 27.9% (26.7–29.1) | 0.82 (0.67–1.00) | 43.9% (42.6–45.3) | 1.08 (0.90–1.30) | 13.5% (12.7–14.3) | 1.48 (1.17–1.87) | 21.8% (20.9–22.7) | 1.40 (1.17–1.68) |
10–14 GPs | 26.2% (24.3–28.0) | 0.82 (0.66–1.02) | 45.7% (43.4–47.9) | 1.15 (0.93–1.40) | 14.0% (12.7–15.2) | 1.39 (1.08–1.79) | 22.9% (21.4–24.5) | 1.36 (1.11–1.67) |
15 + GPs | 28.0% (24.4–31.5) | 0.80 (0.62–1.04) | 42.5% (38.8–46.2) | 1.02 (0.80–1.31) | 13.5% (11.5–15.4) | 1.30 (0.97–1.73) | 23.9% (21.3–26.6) | 1.56 (1.23–1.97) |
GP sex | p < .0001 | p < .0001 | p < .0001 | p < .0001 | ||||
Male | 38.0% (36.7–39.3) | Ref group | 39.1% (37.9–40.4) | Ref group | 9.7% (9.1–10.3) | Ref group | 18.6% (17.8–19.4) | Ref group |
Female | 20.8% (19.9–21.8) | 0.56 (0.51–0.62) | 48.9% (47.6–50.2) | 1.29 (1.18–1.41) | 15.1% (14.4–15.8) | 1.30 (1.16–1.44) | 23.9% (23.0–24.8) | 1.22 (1.11–1.33) |
GP age | p < .0001 | p < .0001 | p < .0001 | p < .0001 | ||||
< 45 years | 22.1% (20.9–23.3) | Ref group | 45.5% (43.7–47.2) | Ref group | 16.4% (15.4–17.4) | Ref group | 26.1% (24.9–27.3) | Ref group |
45–59 years | 28.4% (27.3–29.6) | 1.18 (1.06–1.31) | 45.8% (44.5–47.1) | 1.08 (0.97–1.19) | 12.4% (11.7–13.0) | 0.89 (0.80–1.00) | 20.9% (20.1–21.7) | 0.82 (0.74–0.90) |
60 years + | 40.6% (38.6–42.7) | 1.65 (1.44–1.88) | 37.8% (36.0–39.6) | 0.82 (0.72–0.94) | 8.0% (7.3–8.8) | 0.68 (0.58–0.81) | 16.8% (15.6–18.0) | 0.70 (0.62–0.80) |
Data collection year | n/a | p < .0001 0.94 (0.92–0.95) | p = .009 0.98 (0.96–1.00) | p < .0001 1.09 (1.07–1.11) | n/a | p < .0001 1.05 (1.03–1.06) |